Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leqembi
Biogen's monoclonal antibody for Alzheimer's disease.
Pharma
Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia
Takeda made pipeline cuts in Q3. Innovent reported a head-to-head win against semaglutide. Roche inked a respiratory bispecific deal. And more.
Angus Liu
Oct 31, 2025 8:20am
Biogen ticks up sales outlook again as MS franchise holds strong
Oct 30, 2025 1:37pm
Gilead, Eisai, Vertex meds make Time's list of best inventions
Oct 10, 2025 11:58am
Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia
Sep 5, 2025 9:00am
Eisai scores FDA nod for subcutaneous Leqembi maintenance dose
Aug 29, 2025 5:55pm
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Aug 8, 2025 9:32am
